Khan, Aliya A. http://orcid.org/0000-0003-3733-8956
AbuAlrob, Hajar http://orcid.org/0000-0001-7830-3237
Al-alwani, Hatim http://orcid.org/0000-0001-9036-7903
Ali, Dalal S. http://orcid.org/0000-0002-5378-5548
Almonaei, Khulod http://orcid.org/0000-0002-7293-2654
Alsarraf, Farah http://orcid.org/0000-0001-9426-9702
Bogoch, Earl http://orcid.org/0000-0001-6627-4336
Dandurand, Karel http://orcid.org/0000-0003-1759-8419
Gazendam, Aaron
Juby, Angela G. http://orcid.org/0000-0001-6168-1362
Mansoor, Wasim http://orcid.org/0000-0003-4437-789X
Marr, Sharon
Morgante, Emmett
Myslik, Frank http://orcid.org/0000-0002-2471-592X
Schemitsch, Emil
Schneider, Prism
Thain, Jenny http://orcid.org/0000-0002-0543-1534
Papaioannou, Alexandra http://orcid.org/0000-0001-9412-0932
Zalzal, Paul
Funding for this research was provided by:
Amgen
Article History
Received: 11 August 2022
Accepted: 12 December 2022
First Online: 4 April 2023
Declarations
:
: AK has received research grants from Alexion, Amgen, Ascendis, Chugai, Radius, Takeda, and Ultragenyx and is on the advisory board for Amgen, Amolyt, and Takeda. EB has received unrestricted research grant Amgen Canada and is on the advisory Board for Amgen Canada. AGJ is a consultant for Amgen and Paladin Lab and speaker for Amgen. ES has received a research grant from Amgen and is a consultant for Amgen. JT has received research funding and speaker honorarium from Amgen. AP has received grants, honorarium from Amgen and is on the advisory board for Amgen and Paladin Labs. The other authors declare no competing interests.